Bruno Holthof
Partner @Eqt Life Sciences
Signup · Get unlimited contacts
WORK HISTORY
Partner @Eqt Life Sciences
London, GB
EDUCATION
Harvard Business School
MBA, Health/Health Care Administration/Management
KU Leuven
MD, PhD, Health Economics
SKILLS
ABOUT BRUNO HOLTHOF
Prof. Dr. Bruno Holthof is Visiting Professor of Health Innovation at the University of Oxford and Investment Partner of the EQT Health Economics Funds. Between October 2015 and June 2022, Bruno was the Chief Executive Officer of Oxford University Hospitals (OUH). OUH employs staff across four hospital sites and 44 other locations. During his tenure, OUH made significant investments in people, and the digital and physical infrastructure supporting the world class research, teaching and clinical care taking place in Oxford. Before OUH, he was CEO of the Antwerp Hospital Network (ZNA) from January 2004 until September 2015. During this period, he transformed ZNA into the most profitable hospital group in Belgium. Bruno Holthof is a non-executive director and chair of the clinical strategy and oversight committee at BUPA, a global healthcare company helping people live longer, healthier and happier lives. Bruno is also Chair of the Board of Tristel, a global infection control and disinfection product company and Chair of the Board of Financière de Tubize (FdT). FdT is the reference shareholder of UCB, a global biopharmaceutical company focused on improving lives of people with severe diseases in immunology and neurology. Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organization, and operations. He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.